SS-31 Australia

SS-31 Australia. SS-31 (elamipretide / Bendavia) is a synthetic mitochondrial-targeting tetrapeptide studied in laboratory research — D-Arg-2',6'-dimethyltyrosine-Lys-Phe-NH₂ — referenced across the cardiolipin, mitochondrial-membrane and mitochondrial-protection research literature. The Elite AU Peptides SS-31 is independently HPLC-tested by Janoshik; the certificate of analysis is published on this page and in the lab-reports library, with the measured number and an independently verifiable Janoshik key.

Supplied in 10 mg lyophilised vials, AU-domestic, AUD pricing. Every batch is held until the independent HPLC report comes back within our acceptance threshold; nothing is listed without a certificate on file. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption, not a therapeutic good, not TGA-approved.

SS-31 (CAS 736992-21-5; molecular formula C32H49N9O5, average molecular weight ≈ 640 g/mol; sequence D-Arg-Dmt-Lys-Phe-NH2) is the Szeto-Schiller peptide 31, also referenced as elamipretide or Bendavia — a small synthetic tetrapeptide whose alternating aromatic-cationic motif concentrates it in the inner mitochondrial membrane in research models.

The Szeto-Schiller cell-permeable tetrapeptides — the class that includes SS-31 — were defined by Zhao and colleagues (Journal of Biological Chemistry, 2004), who showed they target the inner mitochondrial membrane and reduce reactive-oxygen-species-driven injury in research models.

The molecular mechanism was established by Birk and colleagues (Journal of the American Society of Nephrology, 2013): SS-31 binds cardiolipin — the phospholipid specific to the inner mitochondrial membrane — protecting cristae architecture and electron-transport efficiency. That cardiolipin-binding mechanism is reviewed by Szeto (British Journal of Pharmacology, 2014).

SS-31 is most-cited in the longevity and mitochondrial-research strands of the catalogue alongside MOTS-c (a mitochondrial-derived peptide) and NAD+ (a cofactor for sirtuin-pathway research); researchers compare these mitochondrial-research tools within a protocol, distinguishing SS-31’s membrane-targeting mechanism from MOTS-c’s genome-encoded origin.

The information provided here is a research-reference summary only. Elite AU Peptides makes no medical, therapeutic, anti-ageing, mitochondrial-protection, or human-use claim about this product. SS-31 is not TGA-approved, is not a therapeutic good, and is supplied strictly for in-vitro and laboratory research use only. Researchers should consult the primary peer-reviewed literature for pathway data and protocol-specific reference values.

Reconstitute the lyophilised SS-31 vial with bacteriostatic water for laboratory handling. Add the diluent slowly down the vial wall and swirl gently rather than shaking. The required volume depends on the protocol’s downstream assay requirements — a 10 mg vial reconstituted in 5 mL of bacteriostatic water yields a 2 mg/mL working stock. Adjust per protocol.

Store the lyophilised powder at −20°C, desiccated and protected from light; once reconstituted, store refrigerated at 2–8°C and use within the documented research window, or aliquot and freeze to avoid repeated freeze-thaw cycles. Tamper-evident packaging; the batch label is the canonical reference for the certificate of analysis published in the lab-reports library.

Shop bacteriostatic water

Australia only. Free shipping over $100. Orders placed before 12pm AEST are dispatched the same business day from Australia.

30-day returns on unused product in original packaging, with prior approval.